ProfileGDS5822 / ILMN_2810882
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 99% 96% 98% 99% 98% 97% 95% 97% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 16736.199
GSM1276600PDAC Late Ablation Control 21447.596
GSM1276601PDAC Late Ablation Control 32835.898
GSM1276602PDAC Late Ablation 15109.299
GSM1276603PDAC Late Ablation 23604.598
GSM1276604PDAC Late Ablation 32552.297
GSM1303940PDAC Late Ablation_anti-CTLA4 11208.195
GSM1303941PDAC Late Ablation_anti-CTLA4 22087.597
GSM1303942PDAC Late Ablation_anti-CTLA4 33423.598